218 related articles for article (PubMed ID: 21372133)
1. Bacterial conversion of folinic acid is required for antifolate resistance.
Ogwang S; Nguyen HT; Sherman M; Bajaksouzian S; Jacobs MR; Boom WH; Zhang GF; Nguyen L
J Biol Chem; 2011 Apr; 286(17):15377-90. PubMed ID: 21372133
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of methenyltetrahydrofolate synthetase from Saccharomyces cerevisiae.
Holmes WB; Appling DR
J Biol Chem; 2002 Jun; 277(23):20205-13. PubMed ID: 11923304
[TBL] [Abstract][Full Text] [Related]
3. The Pup-Proteasome System Protects Mycobacteria from Antimicrobial Antifolates.
Guzzo MB; Li Q; Nguyen HV; Boom WH; Nguyen L
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468462
[TBL] [Abstract][Full Text] [Related]
4. Investigations of Amino Acids in the 5-Formyltetrahydrofolate Binding Site of 5,10-Methenyltetrahydrofolate Synthetase from Mycoplasma pneumonia.
Cooper C; Bryant M; Hogan N; Johann TW
Protein J; 2019 Aug; 38(4):409-418. PubMed ID: 31401777
[TBL] [Abstract][Full Text] [Related]
5. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
Assaraf YG
Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of 5,10-methenyltetrahydrofolate synthetase.
Field MS; Szebenyi DM; Perry CA; Stover PJ
Arch Biochem Biophys; 2007 Feb; 458(2):194-201. PubMed ID: 17250800
[TBL] [Abstract][Full Text] [Related]
7. Mthfs is an Essential Gene in Mice and a Component of the Purinosome.
Field MS; Anderson DD; Stover PJ
Front Genet; 2011; 2():36. PubMed ID: 22303332
[TBL] [Abstract][Full Text] [Related]
8. Regulation of de novo purine biosynthesis by methenyltetrahydrofolate synthetase in neuroblastoma.
Field MS; Szebenyi DM; Stover PJ
J Biol Chem; 2006 Feb; 281(7):4215-21. PubMed ID: 16365037
[TBL] [Abstract][Full Text] [Related]
9. Marked suppression of the activity of some, but not all, antifolate compounds by augmentation of folate cofactor pools within tumor cells.
Zhao R; Gao F; Goldman ID
Biochem Pharmacol; 2001 Apr; 61(7):857-65. PubMed ID: 11274972
[TBL] [Abstract][Full Text] [Related]
10. A new mathematical model of folate homeostasis in E. coli highlights the potential importance of the folinic acid futile cycle in cell growth.
Morgan AE; Salcedo-Sora JE; Mc Auley MT
Biosystems; 2024 Jan; 235():105088. PubMed ID: 38000545
[TBL] [Abstract][Full Text] [Related]
11. Cloning, expression, and purification of 5,10-methenyltetrahydrofolate synthetase from Mus musculus.
Anguera MC; Liu X; Stover PJ
Protein Expr Purif; 2004 Jun; 35(2):276-83. PubMed ID: 15135403
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of antifolate resistance.
Assaraf YG
Cancer Metastasis Rev; 2007 Mar; 26(1):153-81. PubMed ID: 17333344
[TBL] [Abstract][Full Text] [Related]
13. Folylpoly-γ-glutamate synthetase: A key determinant of folate homeostasis and antifolate resistance in cancer.
Raz S; Stark M; Assaraf YG
Drug Resist Updat; 2016 Sep; 28():43-64. PubMed ID: 27620954
[TBL] [Abstract][Full Text] [Related]
14. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines.
Liani E; Rothem L; Bunni MA; Smith CA; Jansen G; Assaraf YG
Int J Cancer; 2003 Feb; 103(5):587-99. PubMed ID: 12494465
[TBL] [Abstract][Full Text] [Related]
15. Novel 6,5-fused ring heterocyclic antifolates: biochemical and biological characterization.
McGuire JJ; Bergoltz VV; Heitzman KJ; Haile WH; Russell CA; Bolanowska WE; Kotake Y; Haneda T; Nomura H
Cancer Res; 1994 May; 54(10):2673-9. PubMed ID: 8168096
[TBL] [Abstract][Full Text] [Related]
16. Anticancer antifolates: current status and future directions.
McGuire JJ
Curr Pharm Des; 2003; 9(31):2593-613. PubMed ID: 14529544
[TBL] [Abstract][Full Text] [Related]
17. Deletion of
Li K; Li T; Yang SS; Wang XD; Gao LX; Wang RQ; Gu J; Zhang XE; Deng JY
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223385
[TBL] [Abstract][Full Text] [Related]
18. Resistance to multiple novel antifolates is mediated via defective drug transport resulting from clustered mutations in the reduced folate carrier gene in human leukaemia cell lines.
Rothem L; Ifergan I; Kaufman Y; Priest DG; Jansen G; Assaraf YG
Biochem J; 2002 Nov; 367(Pt 3):741-50. PubMed ID: 12139489
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of human mitochondrial methenyltetrahydrofolate synthetase activity.
Bertrand R; Beauchemin M; Dayan A; Ouimet M; Jolivet J
Biochim Biophys Acta; 1995 May; 1266(3):245-9. PubMed ID: 7766710
[TBL] [Abstract][Full Text] [Related]
20. Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake.
Drori S; Jansen G; Mauritz R; Peters GJ; Assaraf YG
J Biol Chem; 2000 Oct; 275(40):30855-63. PubMed ID: 10899164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
